Reed Tech

Last chance to register for tomorrow's LexisNexis Reed Tech webinar on Health Canada! Don't miss out on this opportunity to equip your organization with the knowledge and tools needed for success! 📅 Thursday, March 6th | 2 PM ET 👉 Register now: hubs.ly/Q039vrJm0

Did you know? LexisNexis Reed Tech is responsible for over 50% of voluntary XML PM submissions made to Health Canada. Who better to learn from than the experts? Join us Thursday, March 6th for a free, educational webinar. hubs.ly/Q0394NCy0

Sneak Peek: Here's some of what you'll learn in our upcoming webinar | Mastering Health Canada XML PM Monographs: Insights and Strategies from LexisNexis Reed Tech Thursday, 3/6 | 2 PM ET Register now: hubs.ly/Q038tl--0 #HealthCanada #XMLPM #Regulatory

Did you know that missing FDA filing deadlines can lead to your drug products being marked as inactive? Learn more about the implications of inactive status and how to resolve it in our latest blog post. hubs.ly/Q038gW8v0 #Pharmaceuticals #FDACompliance #RegulatoryUpdates

Considering registering for the Reed Tech webinar on Health Canada? Here is why you should. This is a crucial regulation for pharma companies selling in Canada. Understanding these changes is vital to maintaining compliance and market access. Register now: hubs.ly/Q0381Ytk0

Did you know? LexisNexis Reed Tech is responsible for 50% + of voluntary XML PM submissions made to Health Canada. Who better to learn from than the experts? Join us March 6th for a webinar designed to help you prepare for upcoming required submissions. hubs.ly/Q037HGgT0

WEBINAR ANNOUNCEMENT | Mastering Health Canada XML PM Mandates: Insights and Strategies from LexisNexis Reed Tech Register now for this free, educational webinar: hubs.ly/Q037q_F50

It's the last day of #RSIDM2025! Come visit us at booth 303. Our experts are ready and waiting for your questions.

Join us at DIA RSIDM 2025 in Bethesda, MD, booth 303, to explore our eCTD and Compliance as a Service (CaaS) solutions for Medical Device and Pharma. Our team of experts is here to answer any questions you may have about how our services can support your compliance needs.

LexisNexis Reed Tech will be attending DIA #RSIDM25 next week! If you are there, please stop by our booth #313 to learn about the exciting updates going on within our Life Sciences organization. To schedule time with our experts in advance, reach out to pharma@reedtech.com.

The FDA has updated GMDN Codes compliance in the GUDID to enhance standardization and device classification. Read this blog for more information. hubs.ly/Q033jQXr0

Breaking News: FDA to Revoke Authorization for Red No. 3 in Food and Drugs! Read the LexisNexis Reed Tech blog post to learn more: hubs.ly/Q032JrGy0

Exciting Update: The FDA has made enhancements to the GUDID guidance. Stay informed and ensure your compliance by reviewing the updated guidance today! Contact Reed Tech to learn more or get expert help with your UDI submissions - meddevice@reedtech.com. hubs.ly/Q02_-hrD0

Last week, the European Commission released a Q&A on practical aspects related to implementing the gradual roll-out of EUDAMED. In this new blog, we will cover highlights from the document and recommendations for the next steps hubs.ly/Q02-pvHh0

LexisNexis Reed Tech is expanding our Life Sciences Team! We are accepting applications for the following positions. Apply today to join our team of industry experts! Senior Account Executive: hubs.ly/Q02YFJH-0 Strategic Account Sales Executive: hubs.ly/Q02YFLg40

Health Canada is introducing the mandatory use of XML PM in phases, with the first phase taking effect on July 18, 2025. To learn more, read our post below. To get started with your submissions NOW, contact us at pharma@reedtech.com or +1(215) 557-3010. hubs.ly/Q02YzGJp0

Regulatory compliance is key in today's global business landscape. Unique regulations across countries make managing regulatory activities challenging. Partnering with a single, experienced UDI vendor can be highly beneficial. Read our blog to learn more: hubs.ly/Q02YpT8y0

On October 15, 2024, Reed Tech and 1WorldSync hosted a webinar led by Gary Saner and Scott Brown, focusing on how their alliance aids companies in UDI management and GDSN use for compliance and partner requirements. Learn more here: hubs.ly/Q02WRXbS0

Breaking news: FDA has approved a modification to the Opioid Analgesic Risk Evaluation and Mitigation Strategy (OA REMS). Learn more in our full blog post: hubs.ly/Q02WDLHy0

Join LexisNexis Reed Tech for a free, educational webinar examining nuances of the CARES Act. Plus, Gary Saner will fill you in on what to do if you have already missed the first deadline! Register now: hubs.ly/Q02VKfdZ0